ArticleAnnals of surgical oncology2025
ASO Author Reflections: Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Surgical Conversion in Borderline Resectable Cholangiocarcinoma.
Yawen Dong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.